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Abstract Functional recombinant bovine b-lactoglobulin
has been produced by expression in E. coli using an
engineered protein gene and purified to homogeneity by
applying a new protocol. Mutations L1A/I2S introduced
into the protein sequence greatly facilitate in vivo cleavage
of the N-terminal methionine, allowing correctly folded
and soluble protein suitable for biochemical, biophysical
and structural studies to be obtained. The use of gel fil-
tration on Sephadex G75 at the last purification step
enables protein without endogenous ligand to be obtained.
The physicochemical properties of recombinant
b-lactoglobulin such as CD spectra, ligand binding (n, Ka,
DH, TDS, DG), chemical and thermal stability (DGD, Cmid)
and crystal structure confirmed that the protein obtained is
almost identical to the natural one. The substitutions of
N-terminal residues did not influence the binding proper-
ties of the recombinant protein so that the lactoglobulin
produced and purified according to our protocol is a good
candidate for further engineering and potential use in
pharmacology and medicine.
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Bovine b-lactoglobulin (BlgB) is a small protein (18.3 kDa)
belonging to the lipocalin family. Due to BlgB ability to
bind different classes of bioactive compounds, its applica-
tion as a nutrients nanotransporter or drug carrier is currently
an object of intensive studies [1–5]. Most of them are per-
formed with commercially available natural lactoglobulin,
but the use of recombinant protein seems to be a better
alternative. The expression of correctly folded BlgB was
successful for an extended period but only in eukaryotic
systems: insect [6], yeast (P. pastoris [6], S. cerevisiae [8])
and transgenic mice [9]. More recent studies showed that
BlgB can be produced and secreted by Lactobacillus casei
[10] while attempts to express b-lactoglobulin in E. coli
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have continued to fail due to incorrect protein folding. The
expression systems used for lactoglobulin production were
reviewed in details by Ariyaratne et al. [11].
The strategy for successful expression of b-lactoglobu-
lin in E. coli was discovered by Ponniah et al. [12], who
produced soluble and correctly folded BlgB in Origami B
cells. Folding of recombinant protein in the bacteria cyto-
plasm was possible due to its co-expression with DsbC
(E. coli cytoplasmic disulphide bond isomerase), which
facilitates disulphide bridges formation in the reducing
environment of bacterial cytoplasm.
Potential utilisation in medicine of small proteins
belonging to the lipocalin family has recently intensified
their studies [13]. Such research has been aimed at pro-
ducing engineered proteins that can specifically recognise
receptors or bind desired low molecular weight ligands
[14]. An increased affinity to selected molecular targets is
achieved by introducing mutations into the binding site
region. In modified lipocalins, substituted residues interact
specifically with ligands and change the binding pocket
plasticity [15].
The process of protein engineering requires an expres-
sion system which allows obtaining high yields of pure and
biologically active protein molecules. Engineered lipoca-
lins, called Anticalins, are usually produced in prokaryotic
expression systems; however, due to the presence of
disulphide bonds in their structure, during expression they
are directed to the periplasmic space (e.g. by N-terminal
OmpA signal peptide), in which efficient S–S bridge for-
mation occurs. Anticalins also may have affinity tag at the
C-terminus to facilitate protein purification [16], but it
often needs to be removed in vitro before structural and
other studies. This experimental strategy, however, gener-
ates additional steps in the protein purification protocol.
As other proteins from lipocalin family, BlgB can be
re-engineered to gain specificity of binding selected
bioactive ligands, and this requires heterologous protein
production in the appropriate expression system. Such
system should be not expensive and enable to produce the
correctly folded protein in high amounts needed for
medical and structural studies. In this context, strategy for
BlgB production in E. coli with co-expression of the
DsbC isomerase [12] seems to be especially valuable. We
have repeated this procedure (protocol #1), but we have
found that obtained BlgB has physicochemical properties
different than natural lactoglobulin isolated from bovine
milk. Detailed studies, presented below, revealed the
presence of uncleaved N-terminal methionine and
endogenous fatty acid tightly bound in the binding pocket
which significantly influenced properties of the recombi-
nant protein and affected binding of pharmaceutical
agents.
Here, we present a modification of expression and
purification protocol (protocol #2) which allows producing
in Origami B (DE3) cells fully functional BlgB. To com-
pare properties of recombinant lactoglobulin produced
using different protocols, we used a range of techniques.
Secondary and tertiary structure in solution was inspected
by CD spectra. Thermal and chemical denaturation moni-
tored by CD spectra changes was used to determine protein
stability. The thermodynamic parameters of model ligand
binding have been measured using isothermal titration
calorimetry. Origins of different properties observed for
proteins produced with the use of different protocols were
explained on the basis of MS and crystal structures.
Materials and Methods
Materials
All chemicals used for protein purification and crystal-
lization, e.g. phosphate and Tris–HCl buffer ingredients,
salts: NaCl, (NH4)2SO4, HCl, tri-sodium citrate in analyt-
ical grade, were purchased from IDALIA (Poland) or
Avantor Performance Materials Poland S.A.
Antibiotics (ampicillin sodium salt, kanamycin mono-
sulphate tetracycline chloride) and LB broth Miller (Bio-
Shop) were purchased from LabEmpire. Agar and IPTG
were purchased from A&A Biotechnology (Poland). Nat-
ural (milk) b-lactoglobulin isoform B used as a reference in
spectroscopic and calorimetric studies was purchased from
Sigma-Aldrich.
Construction of Expression Vector and Mutagenesis
Genes coding bovine b-lactoglobulin isoform B (BlgB,
UNP: P02754) and bacterial disulphide bond isomerase
DsbC (DsbC, UNP: P0AEG6) were chemically synthesised
and optimised for the expression in E. coli by GeneArt
(Germany). In both cases, the short sequences responsible
for the extracellular localisation of proteins were omitted.
The expression vector was generated according to Ponniah
et al. [12]: DsbC was cloned into MCS I while BlgB was
introduced into MCS II of the pETDuet-1 vector (Invitro-
gen) using NcoI/HindIII and NdeI/KpnI set of endonucle-
ases. The use of the NcoI restriction site eliminated the
presence of His-tag at the N-end of DsbC and duplicated
TAA codon at the end of BlgB preventing the formation of
S-tag at the C-end of rBlgB. Before transformation, the
modified vector pETDuet-1/DsbC/BlgB was sequenced to
prove that no frameshift or mutation took place during the
cloning procedure.
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Initial amino acids in b-lactoglobulin were modified by
QuikChange method. A pair of complementary mutagenic
primers (FOR:50GGAGATATACATATGGCCTCAGT TA
CCCAGACCATG30 and REV:50CATGGTCTGGGTAAC
TGAGGCCATATGTATATCTCC30) was applied to
replace codons for Leu1 and Ile2 with Ala and Ser during
PCR. pETDuet-1/DsbC/BlgB vector served as a matrix for
this reaction. In the next step, the methylated matrix was
digested with DpnI restriction enzyme and newly synthe-
sised DNA (pETDuet-1/DsbC/L1A/I2S-BlgB) was used to
transform E. coli DH5a competent cells. The presence of
the desired mutation in obtained colonies was confirmed by
sequencing.
Expression
Competent E. coli Origami B (DE3) (Novagen) cells were
transformed with pETDuet-1/DsbC/BlgB or pETDuet-1/
DsbC/L1A/I2S-BlgB vector and grown overnight in
LB–agarose plates containing 100 lg/ml ampicillin,
15 lg/ml kanamycin and 12.5 lg/ml tetracycline. Single
colonies were transferred to 5 ml of LB medium containing
the same antibiotics and grown overnight at 37 C. Next
day, liquid culture was increased to 50 ml and incubated
overnight at 37 C. Fifty ml of overnight culture was added
to 1.2 L of LB media supplemented with the same antibi-
otics, and cultures were incubated for 3–6 h at 37 C
applying constant stirring 100 rpm, until OD600 reached
0.5–0.7 (pETDuet-1/DsbC/BlgB) or 1.0–1.2 (pETDuet-1/
DsbC/L1A/I2S-BlgB vector). When OD600 reached desired
value, protein expression was induced by adding IPTG to its
final concentration 500 lM. After induction, the tempera-
ture was decreased to 25 C and cultures were incubated for
3–4 h (pETDuet-1/DsbC/BlgB vector) or overnight (pET-
Duet-1/DsbC/L1A/I2S-BlgB vector), with constant stirring
200 rpm. After this time, cells were harvested by centrifu-
gation at 5000 rpm and frozen at -80 C.
Purification Protocol #1
The described below purification protocol was applied to
rBlgB (product of pETDuet-1/DsbC/BlgB) and sBlgB
(product of pETDuet-1/DsbC/L1A/I2S-BlgB). This purifi-
cation protocol follows the procedure described by [12]
with some modifications. Cell pellet (approximately 4–5 g)
were re-suspended in 20 ml of 50 mM phosphate buffer
(pH 6.5) containing PMSF. Cells were disrupted by soni-
cation (3 9 5 min) and centrifuged at 15,0009g. Clarified
cell lysate was loaded on chromatography XK 16/20 col-
umn (GE Healthcare) packed with Fractogel EMD TMAE
(S) resin (Merck Millipore), equilibrated previously with
the 50 mM phosphate buffer pH 6.5. Proteins were eluted
using a linear gradient of 2 M NaCl (Fig. 1). Collected
fractions were analysed by SDS-PAGE, and those con-
taining b-lactoglobulin were pooled and dialysed overnight
to 50 mM phosphate buffer pH 7.5.
After dialysis, lactoglobulin concentration was esti-
mated by measurement of A280 (e = 17 600 M
-1 cm-1
[17]). The protein solution was diluted to concentration
*1 mg/ml with phosphate buffer, and then, 0.1 M HCl
was added dropwise with continuous stirring, to achieve a
pH of 2.6. Solid NaCl was added to 7 % (w/v) to precip-
itate first protein fraction. Precipitated proteins were
removed by centrifugation at 15,0009g, and the super-
natant containing b-lactoglobulin was recovered. Solid
NaCl was added to reach a concentration of 30 % (w/v),
and proteins precipitated at this step (containing predomi-
nately rBlgB or sBlgB, Fig. 2) were harvested by cen-
trifugation at 15,0009g. The pellet was re-suspended in a
small volume of 50 mM phosphate buffer pH 7.5 and
dialysed overnight at 4 C. Protein purity and homogeneity
were checked by SDS-PAGE and size exclusion chro-
matography at Superdex75 10/300 GL (GE Healthcare)
(Fig. 2).
Chemical, N-terminal protein sequencing by the Edman
method (Procise 491 Sequencer, Applied Biosystems,
BioCentrum, Poland) of first five amino acids was per-
formed for rBlgB being a product of pETDuet-1/DsbC/
BlgB expression. Prior to sequencing, protein was
deformylated using the protocol described by Hirano et al.
[18] (Fig. S1).
The molecular weight of lactoglobulin (rBlgB and
sBlgB) was determined using mass spectrometry (MS).
Mass spectra were recorded with the use of an MALDI-
TOF/TOF mass spectrometer (ultrafleXtreme, Bruker
Daltonics) equipped with smartbeamTM laser operated at
1 kHz repetition rate. Spectra acquisition and pre-pro-
cessing were performed with flexControl and flexAnalysis
software, both from Bruker. Spectra were registered within
m/z range of 5000–20,000 in a linear positive mode with
25 kV acceleration voltage. Multiple charge state analysis
(MCSA) [19] was employed for the determination of pro-
tein mass weight. 2,5-Dihydroxyacetophenone (DHAP)
was used as a matrix, while Protein Calibration Standard I
(Bruker) was exploited for calibration of the TOF analyser.
Purification Protocol #2
This protocol was applied only to L1A/I2S-substituted
variant (sBlgB). The initial steps of protein purification were
the same as in protocol #1, but after ion-exchange chro-
matography at Fractogel EMD TMAE (S), instead of salting
out by NaCl, the second chromatography step was applied.
Fractions containing lactoglobulin, eluted from an anion-
exchange resin, were analysed by SDS-PAGE, and those
containing the highest content of L1A/I2S were pooled and
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loaded on XK 16/20 column (GE Healthcare) packed by
Sephadex G75 (Pharmacia). Proteins were eluted using
50 mM phosphate buffer pH 6.5 (Fig. 3). Eluted fractions
were analysed by SDS-PAGE (insert in Fig. 3).
Circular Dichroism
CD spectra of rBlgB and sBlgB were recorded at 20 C on
a JASCO J-710 spectropolarimeter using 50 mM phos-
phate buffer pH 6.5 or 7.5. In the case of pH-dependent
measurements, buffer containing 20 mM acetate, 20 mM
phosphate, 20 mM Tris and 20 mM borate was used and
the pH was adjusted to the desired value by adding HCl or
NaOH. Each sample was prepared at least a half-hour
before measurement.
The protein concentrations 10–15 lM and the 200 lm
path length were used for far-UV measurements, while the
protein concentrations 50 lM and the 5 mm path length
were used for near-UV measurements. Three scanning
acquisitions were accumulated and averaged to yield the
Fig. 1 Initial step of
lactoglobulin purification on
Fractogel TMAE (S) (the
example of sBlgB). Proteins
were eluted using 0–50 %
gradient of 2 M NaCl in 50 mM
phosphate pH 6.5. sBlgB was
eluted in peak A (fractions
marked by arrows on SDS-
PAGE gel)
Fig. 2 SDS-PAGE analysis of rBlgB purification: Line 1 pooled
fractions collected in anion-exchange chromatography, line 2 super-
natant after salting out by 7 % (w/v) NaCl, line 3 marker (a 14.2 kDa,
b 20.1 kDa, c 24 kDa, d 29 kDa, e 36 kDa, f 45 kDa, g 66 kDa), line
4 pellet after salting out by 7 % (w/v) NaCl, line 5 pellet after salting
out by 30 % (w/v) NaCl re-suspended in phosphate buffer (diluted
rBlgB), line 6, 7 concentrated rBlgB (15 and 20 mg/ml), line 8 natural
b-lactoglobulin purchased from Sigma-Aldrich (20 mg/ml). Size
exclusion chromatography on Superdex200 10/300 GL performed
for rBlgB#1 (corresponds to lines 6 and 7 on gel)
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final spectrum. CD spectra were corrected for the buffer
baseline. The ellipticity was converted to a difference in
extinction coefficients. The spectra were normalised to the
peptide bonds concentration for far-UV and the protein
concentration for near-UV.
The secondary structure composition was estimated
using CDPro spectra deconvolution software developed by
Sreerama and Woody [20]. The best fits were obtained
using CONTINLL algorithm and the SDP42 reference
spectrums data set.
Thermal Denaturation
Equilibrium thermal unfolding of the sBlgB#2 was moni-
tored by CD on a JASCO J-710 spectropolarimeter using
1-mm path length quartz thermostated cuvette sealed with a
Teflon stopper to avoid evaporation during thermal
unfolding. The measurements were taken at 50 mM phos-
phate buffer pH 6.5. The temperature of the cuvette in the
sample beam was controlled by Julabo circulating water
bath. A signal at 200 nm was recorded as a function of
temperature over a range of 20–95 C. The heating rate in
the experiments was 1.0 C per minute. The raw temper-
ature scans were processed using a first-order Savitzky–
Golay algorithm of Origin software (version 9.1.0) with a
window of 20 points to determine the first-order derivatives
and Tm values as a mean value of three independent runs.
Chemical Denaturation
Urea-induced unfolding of the protein was monitored by
CD on a JASCO J-710 spectropolarimeter using 1-mm path
length quartz cuvette. A signal at 220 nm was recorded in
50 mM phosphate buffer pH 6.5 at room temperature. The
samples were prepared 1 day before experiment by mixing
a stock solution of the protein with 10 M urea solution in
the same buffer to a final concentration of 5 lM sBlgB#2
and incubated overnight at room temperature. Global
analysis of data in triplicates was conducted using Origin
software assuming a two-state mechanism according to
methods described in [21].
Isothermal Titration Calorimetry
All ITC experiments, both for recombinant proteins and
milk lactoglobulin used as a reference, were carried out at
25 C using a VP-ITC instrument (MicroCal, Northamp-
ton, MA, USA). SDS binding experiments were performed
according to methods described in our previous paper [22]
using 50 mM phosphate buffer pH 6.5 or 50 mM Tris–HCl
buffer pH 7.5. Data analysis was performed using
MicroCal Origin scientific plotting software according to
the model of the single set of identical independent sites.
Standard deviations of determined parameters were calcu-
lated from at least two titration runs. In the case of data
without typical sigmoidal dependence of heats versus
reagents molar ratio, fixed value of enthalpy equal to
-31.07 kJ/mol was used [22].
Crystallization
Recombinant lactoglobulin was crystallised using vapour
diffusion method in hanging drop set-up. Small
(*0.1–0.2 mm), poorly diffracting crystals of rBlgB
appeared only in drops formed by mixing 1–2 ll of protein
(concentration between 12.5 and 25 mg/ml) and 1–2 ll of
Fig. 3 Purification of sBlgB#2
on Sephadex G75. Fractions
B contained almost pure L1A/
I2S-BlgB
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1.8–3.0 M (NH4)2SO4 solution in 0.2 M Tris–HCl buffer
pH from 7.8 to 8.8. Larger crystals (*0.4 mm) suitable for
data collection were obtained in drops containing 1 ll of
1.34 M sodium citrate in 0.1 M Tris pH 7.5 and 1 ll of
protein (30 mg/ml) for sBlgB#1 or 1 ll of 2.3 M (NH4)2-
SO4 in 0.5 M Tris–HCl pH 8.5 for sBlgB#2.
Data Collection, Structure Solution and Refinement
X-ray diffraction data for rBlgB crystal were collected at
MAX-LAB synchrotron facility at I911-3 beamline
(1.00 A˚). Crystals were washed in cryoprotectant (20 %
v/v glycerol) and immediately transferred to nitrogen
cryostream (100 K). Data were recorded on CCD MAR
165 detector and processed using XDS [23] and HKL2000
[24].
Diffraction data for sBlgB crystals were collected at
SuperNova diffractometer (Rigaku Oxford Diffraction)
using CuKa radiation (1.54 A˚) generated by microfocus
radiation source (0.8 mA and 50 kV). Data were collected
at 120 K using 20 % v/v glycerol as a cryoprotectant and
recorded on 135-mm Atlas CCD detector. Data were pro-
cessed using CrysalisPro (Rigaku Oxford Diffraction) and
Scala [25] form CCP4 package [26].
Structures of rBlgB, sBlgB#1 and sBlgB#2 were solved
by molecular replacement with Phaser [27] using bovine
b-lactoglobulin structure 1BSY or 1B8E as a starting
model. Structures were refined by Refmac5 [28], while
Fourier maps were investigated using Coot [29]. Statistics
of data collection and structure refinement are summarised
in Table 1. Structures were deposited in Protein Data Bank
(PDB) as entries: 5K06, 5HTD, 5HTE.
Results
Expression in Origami B (DE3) and Purification
of Recombinant b-Lactoglobulin
The optimal expression time maximising the amount of
soluble protein produced in Origami cells was 3–4 h for
rBlgB and 18–20 h (overnight) for sBlgB at room tem-
perature. To monitor expression level, samples of cell
culture were collected and analysed by SDS-PAGE.
Inspection of gels (Fig. S2) clearly showed that bands
having a molecular weight about 24 kDa (DsbC) and
18 kDa (BlgB) appeared 1 h after induction and their
intensity increased with time.
The typical yield of soluble protein (purity B90 %,
Fig. 3) obtained from 4 to 5 g wet cells produced in 1 L
culture medium was about 15–20 mg of rBlgB or sBlgB
(protocol #1) and about 30–40 mg of sBlgB (protocol #2).
Folding of Recombinant Bovine b-Lactoglobulin
Produced in Origami B (DE3)
The correctness of recombinant lactoglobulin (rBlgB and
sBlgB) folding was routinely verified by CD spectra in the
far and near-UV range (Fig. 4). The position of extremes
did not depend on the sample, while amplitudes strongly
depended on the type of the protein and purification pro-
tocol indicating a more dynamic structure of all recombi-
nant proteins in comparison with milk b-lactoglobulin.
Despite these differences, the quantitative analysis of
spectra using CDPro software gave for all analysed
recombinant proteins contents of the secondary structures
being in agreement with that calculated from crystallo-
graphic data (Table S1). The best compliance to signal
observed for milk protein at the near-UV range was for
sBlgB#2. The amplitude of both troughs at about 286 and
293 nm and their ratio are close to measured earlier
[30, 31].
Ligand Binding by Recombinant Bovine
b-Lactoglobulin Produced in E. coli
Because SDS binding to lactoglobulin is well characterised
in the literature [22, 32], to verify the ability of the
recombinant protein (rBlgB, sBlgB#1 and sBlgB#2) to
Table 1 Statistic of data collection and structure refinement
rBlgB sBlgB#1 sBlgB#2
PDB 5K06 5HTD 5HTE
Endogenous ligand Yes Yes No
Space group P6422 P3221 C2221
Unit cell [A˚] a = 106.65 a = 53.49 a = 54.85
b = 106.65 b = 53.49 b = 79.09
c = 59.31 c = 111.04 c = 65.70






Completeness [%] 99.6 (100) 98.9 (98.8) 97.4 (97.8)
Redundancy 19.7 (20.4) 2.8 (2.3) 2.5 (1.8)
Rmerge 0.073 (0.228) 0.072 (0.348) 0.047 (0.616)
I/rI 64.7 (16.1) 8.4 (1.8) 13.7 (2.0)
Reflections (test set) 6058 (1043) 5367 (1293) 4456 (1187)
R [%] 21.3 20.1 21.1
Rfree [%] 32.4 27.2 30.3
rmsd bonds [A˚] 0.012 0.007 0.010
rmsd angles [] 1.676 1.116 1.465
Ramachandran statistics
Favoured [%] 93 95 90
Allowed [%] 4 5 10
Outliers [%] 2 0 0
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bind ligands, we selected it as a model ligand. Observed
initial heat release (Fig. 5) was consistent with effect
measured for BlgB isolated from milk [22, 32, 33]. The
binding constant Ka and thermodynamic parameters of SDS
binding are presented in Table 2. The stoichiometry for
rBlgB and sBlgB#1 was in the range from 0.15 to 0.4,
while for sBlgB purified by protocol #2 stoichiometry was
above 0.8.
Crystal Structure of rBlgB Purified by Protocol #1
Crystals of rBlgB obtained from ammonium sulphate
poorly diffract X-rays, and data collection required the use
of synchrotron radiation. The unit cell symmetry P6422
was not observed previously for b-lactoglobulin. The
asymmetric unit contains one protein chain (Fig. 6). With
the exception of GH loop which is disordered, the electron
density is well defined for entire protein chain and shows
that disulphide bridges are correctly formed. The density
also allowed to resolve two alternative conformations of
N-terminal part of the polypeptide chain located on crys-
tallographic twofold axis. Additional electron density, not
observed previously in structures of bovine milk lac-
toglobulin, was found near N-terminal fragment of protein
molecules. Mass spectrometry revealed that molecular
weight [M ? H]? of rBlgB was 18,409.8 (±5) Da, about
128.6 Da more than calculated from its sequence using
Compute pI/Mw from Expasy server. This difference cor-
responds within experimental error to the mass of
methionine (132 Da). Chemical sequencing (see ‘‘Purifi-
cation Protocol #1’’ section and Fig. S1) confirmed the
presence of the uncleaved N-terminal methionine Met0.
Fourier maps also showed unexpected elongated density in
the hydrophobic pocket of b-barrel. 10–16-carbon long
fatty acids were modelled, and the best fit has been
observed for 14-carbon myristic acid (MYR) (Fig. 6). As
the rBlgB was crystallised without the addition of potential
ligands, it must have an endogenic origin.
Crystal Structure of sBlgB Purified by Protocol #1
The space group P3221 and unit cell parameters of sBlgB
crystals correspond very well to the trigonal form of natural
bovine b-lactoglobulin. The crystal structure was in
agreement with MS results, indicating that N-terminal
methionine has been successfully cleaved (determined
m.w. was 18,211.7 ± 5 Da, while the calculated was
18,213.05 Da). The electron density is well visible for
almost entire protein chain; the exception is flexible loop
GH. Electron density maps confirmed that disulphide
bridges, between residues Cys66–Cys160 and Cys106–
Cys119, are correctly formed, so the applied system of
BlgB co-expression with DsbC works efficiently for lac-
toglobulin sequence carrying mutation L1A/I2S.
Similarly to previous structure, electron density maps
revealed the presence of a ligand in the b-barrel, even
though no ligand was added to protein solution and crys-
tallization drops (Fig. 6). The electron density in the
binding pocket was similar to that observed in the struc-
tures of lactoglobulin–fatty acid complexes, and it has been
interpreted as a myristic acid [22, 34]. Superposition of
sBlgB structure with BlgB-MYR complex (PDB: 3UEV)
Fig. 4 Far-UV (left panel) and near-UV (right panel) CD spectra of BlgB (solid line, from [27]), rBlgB (dash-dot line), sBlgB#1 (dashed line)
and sBlgB#2 (dotted line) in 0.05 M phosphate buffer pH 7.5, 20 C. De was normalised by peptide bonds or protein concentration
Mol Biotechnol (2016) 58:605–618 611
123
revealed almost the same position of ligand in both struc-
tures (Fig. 6c).
Crystal Structure and Properties of sBlgB Purified
by Protocol #2
The crystals obtained using recombinant sBlgB purified by
protocol #2 had space group symmetry C2221, the same as
observed several times for natural, unliganded protein [35, 36].
The electron density is well defined except for flexible loops
CD and GH and disordered C-terminal fragment 155–162.
Contrary to protein purified by protocol #1, there is no evidence
of any ligand bound in the binding site (Fig. 6d). Superposition
of sBlgB#2 and three natural b-lactoglobulin structures of the
same space group symmetry gave r.m.s.d. values for Ca in the
range 0.39–0.47 A˚ (Fig. 7a, b ).
Fig. 5 Calorimetric isotherms of SDS binding to rBlgB (left panel)
and sBlgB#2 (right panel). The experiments were performed at 25 C
in 50 mM Tris–HCl buffer pH 7.5 and 50 mM phosphate buffer pH
6.5, respectively. The protein and ligand concentrations were 28 and
500 lM for rBlgB and 37 and 100 lM for sBlgB#2. The solid line
represents the best fit of experimental data to the one site binding
model. A fixed value of enthalpy (-31.07 kJ/mol) was used in case of
rBlgB
Table 2 Thermodynamic
parameters of SDS binding
Ligand binding
n Ka (910
5 M-1) DG (kJ/mol) DH (kJ/mol) TDS (kJ/mol)
rBlgBa 0.17–0.41 5.3 ± 1.5 -32.6 ± 0.7 -31.07c n.d.
sBlgB#1a 0.19–0.38 1.6 ± 0.7 -29.5 ± 0.9 -31.07c n.d.
sBlgB#2b 0.82–0.84 4.2 ± 0.2 -32.1 ± 0.1 -17.6 ± 0.2 14.54 ± 0.1
Milk BlgBb 1.01–1.05 3.6 ± 0.6 -31.7 ± 0.5 -20.3 ± 0.1 11.45 ± 0.2
a 50 mM Tris–HCl, pH 7.5
b 50 mM phosphate, pH 6.5
c A constant value taken from [22]
612 Mol Biotechnol (2016) 58:605–618
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ITC experiments performed using SDS as a model
ligand provided binding parameters (Table 2) being in
good agreement with parameters obtained by us in refer-
ence experiments with milk Blg in the same conditions and
others [33].
To further characterise sBlgB#2 protein, we also per-
formed thermal and chemical denaturation experiments.
The results of urea-induced denaturation presented in
Table 3 show that the stability of a recombinant protein is
lower than of milk protein by about 11.5 kJ/mol, but their
Cmid values are similar. Also, the thermal denaturation of
the protein analysed as the temperature dependence of the
CD signal derivative measured at 200 nm indicates lower
stability of sBlgB#2 in comparison with milk protein. The
Tm value decreased from 79.4 ± 1.4 C for milk protein to
72.8 ± 0.4 C for sBlgB#2. A storage stability of sBlgB#2
was monitored by measurements of CD spectra. We did not
observe any change in a term of 2 weeks at room tem-
perature and at 4 C (Fig. S3).
Because it is known that pH strongly modifies the Blg
properties, especially its ability to bind ligands [37–39],
CD signal versus pH was measured for sBlgB#2 and nat-
ural BlgB isolated from milk and no significant differences
have been found (Fig. S4).
Discussion
Expression of b-Lactoglobulin in E. coli
Although recombinant bovine lactoglobulin has been suc-
cessfully produced in eukaryotic expression systems
(Pichia pastoris) [7], the production of correctly folded
protein in bacteria was unsuccessful until 2010. The
Fig. 6 Electron density map around endogenous ligand bound in
b-barrel of a rBlgB (1.2 r) and b sBlgB#1 (1.0 r). c The position of
ligand in sBlgB#1 (cyan) and in milk lactoglobulin complex with
myristic acid (orange, PDB: 3UEV). d Electron density map (1.0 r)
around residues in empty b-barrel in sBlgB#2 (Color figure online)




1B8E, C2221). b Superposition
of lactoglobulin structures:
rBlgB (chain C: magenta),
PDB: 1BSY (blue), PDB: 3BLG
(grey), PDB: 1B8E (orange),
PDB: 1BEB (yellow) (Color
figure online)
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breakthrough was made by Ponniah et al. [12] who found
that BlgB must be co-expressed in E. coli Origami cells
together with bacterial disulphide bond isomerase (DsbC).
We used this expression system and purification protocol
without any major modifications to produce recombinant
lactoglobulin in our laboratory. However, we have noticed
that obtained protein (rBlgB) had properties different than
protein isolated from milk.
The ITC experiments gave Ka values of SDS binding to
rBlgB in agreement with values obtained using milk pro-
tein in the same conditions [22, 33], but the binding stoi-
chiometry in the range 0.17–0.41 was much lower than
expected. This result could be explained by partially
incorrect folding of the protein or by the occupation of the
binding pocket by endogenous ligand. The second
hypothesis has been confirmed by the crystal structure of
rBlgB which showed the presence of endogenous aliphatic
ligand bound inside the b-barrel (Fig. 6a).
Mass spectrometry revealed that molecular weight
[M ? H]?of rBlgB was higher than the expected value by
128.59 Da indicating the possible presence of uncleaved
N-terminal methionine. The chemical sequencing of rBlgB
unambiguously confirmed this hypothesis (Fig. S1). The
uncleaved N-terminal Met is sometimes observed in
recombinant proteins, and its impact on protein properties
and stability can be positive, insignificant or negative.
Uncleaved N-terminal methionine was found e.g. in
recombinant hen egg white lysozyme produced in E. coli.
In this case, it was found that protein with additional Met
had lower refolding rate and solubility in comparison with
wild-type protein [40]. The N-terminal methionine present
in recombinant rubredoxin from Pyrococcus furiosus had a
moderate effect on protein thermal stability and structure
[41]. Crystal structure of recombinant rubredoxin showed
that extra methionine has changed only the hydrogen bond
pattern in its close neighbourhood [41].
The positive effect of the N-terminal Met on protein
stability was observed in recombinant ribonuclease A
(RNase A) [42]. Enzyme containing uncleaved N-terminal
Met had enzymatic activity close to that of bovine RNase
A, while its transition midpoint for thermal unfolding was
1.5 C higher than that of natural bovine RNase A [42].
Contrary, N-terminal methionine, which was detected in
recombinant goat a-lactalbumin expressed in Escherichia
coli, remarkably decreased the stability of the protein and
increased its apparent net negative charge. It also affected
the packing of a-lactalbumin molecules in the crystalline
phase and altered crystal symmetry [43].
Likewise, in rBlgB uncleaved starting methionine neg-
atively influenced properties of protein, affecting not only
binding stoichiometry but also crystallization conditions
and intermolecular interactions in the crystalline phase.
The crystallization trials showed that rBlgB could be
crystallised only from the high concentration of ammonium
sulphate (2.8–3.0 M) and such conditions produced small,
poorly diffracting crystals with morphology and symmetry
substantially different than observed for natural protein.
The origins of such differences have become understood
later, after careful analysis of crystal structure. They are the
effect of partial disorder around N-terminus fragments with
uncleaved Met, which also affects positions of other resi-
dues. Superposition of rBlgB and known structures of milk
lactoglobulin (1BSY, 1BEB and 3NQ3) revealed that
N-terminal parts of the protein chain and AB loop have
position shifted by about 2–5 A˚ in comparison with its
location in trigonal structures.
Hirel et al. [44] have found that in bacteria cells, the
catalytic efficiency of N-terminal methionine excision by
MAP (L-methionine amino peptidase) depends on the nat-
ure of the second amino acid in the polypeptide chain.
Efficiency of MAP decreases when the side chain length of
the penultimate amino acid increases. This dependence is
related to the structure of the enzyme active site in which
each subsite is able to accommodate side chain with
specified dimensions [44, 45]. The rate of N-terminal Met
processing is the highest for residues possessing short side
chains (Gly, Ala, Pro, Ser, Thr, Val) while the sequence of
BlgB starts with relatively large leucine and isoleucine. To
eliminate N-terminal Met, we have engineered two muta-
tions (L1A/I2S), which were designed according to more
Table 3 Thermodynamic
parameters of protein chemical
unfolding for protein
concentration in range from 0.1
to 0.73 mg/ml
Experimental conditions Chemical denaturation parameters
pH Ionic strength (mM) DGD (kJ/mol) m (kJ/mol M) Cmid (M) Ref.
Recombinant sBlgB#2
6.5 50 16.2 ± 2.4 3.9 ± 0.6 4.18 This work
Natural (milk) BlgB
6.5 50 27.7 ± 5.4 6.5 ± 1.3 4.26 This work
7.0 50 25.0 ± 1.5 6.5 ± 0.35 3.8 [47]
6.2 10 12.1 ± 5.5 3.77 ± 1.26 3.2 ± 0.8 [21]
6.85 10 27.8 6.4 4.35 [48]
8.3 10 20.5 ± 4.6 5.02 ± 0.85 3.9 ± 0.4 [21]
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recent findings by Frottin et al. [45]. They observed that
most efficient cleavage of N-terminal Met occurs when an
N-terminal sequence is Met–X–Y, where X is Gly, Ala,
Pro, Ser and Y is Gly, Ala, Trp, Met or Ser. We have
decided to replace Leu1 by Ala, which is the nonpolar
residue with shorter side chain, so such substitution in
contrast to Gly, Pro or Ser should not affect the protein
properties significantly. In the second position, Ile has been
replaced by Ser, to avoid residue with large side chain (Trp,
Met) and duplication of residues (Ala).
The presence of additional Met at N-terminus was not
reported by Ponniah et al. [12] who checked only CD and
NMR spectra of recombinant lactoglobulin. These tech-
niques are also not sensitive enough to show the differ-
ences, especially when the core of protein made of b-barrel
is correctly folded. Interestingly, the presence of uncleaved
Met was also not recognised by Crowther et al. [46] who
expressed recombinant caprine b-lactoglobulin using the
same DsbC-co-expression system. The recombinant goat
protein was crystallised, and structure was solved with
ultra-high resolution (PDB: 4TLJ). But careful investiga-
tion of electron density maps that are available for this
structure on Electron Density Server revealed an extra
electron density near N-terminus in which methionine can
ideally be fitted, as predicted.
Purification Protocols of Recombinant
b-Lactoglobulin
The new lactoglobulin variant carrying substitutions L1A/
I2S at N-terminus (sBlgB) has been produced and puri-
fied by two different protocols. The sBlgB purified by
protocol #1, based on the method proposed by Ponniah
et al. [12], had spectroscopic properties corresponding very
well to milk protein (Fig. 4) and crystallised in the con-
ditions typical for natural protein. However, ITC tests were
constantly showing a very low stoichiometry of SDS
binding, with the values similar to the observed for rBlgB
(Table 2). These results indicated that the binding site of
sBlgB#1 was probably occupied by endogenous ligand.
This hypothesis was verified by the crystal structure, which
confirmed the presence of the endogenous ligand in the
b-barrel. Elongated electron density observed in the bind-
ing site was interpreted as 14-carbon myristic acid. How-
ever, its origin is unknown. It might be either fatty acid
present in cytoplasm and bound during expression or fatty
acid from disrupted cell membranes which has bound
during purification. The second possibility seems to be the
most probable because the modification of a purification
protocol allowed to obtain the sBlgB with empty b-barrel
(Fig. 6d).
Purification of L1A/I2S BlgB variant by protocol #1
requires one chromatography step and two time-consuming
overnight dialysis procedures, but the efficiency of purifi-
cation is relatively low. For these reasons, we have decided
to modify this protocol. In the protocol #2, instead of two
salting out and dialysis steps, we have used the size
exclusion chromatography on Sephadex G75 at pH 6.5.
Such replacement allowed us to obtain the recombinant
L1A/I2S BlgB variant with the unblocked binding site
(sBlgB#2). The protocol #2 also eliminates the need of
strong acidification of protein solution to pH 2.6 which was
necessary to precipitate E. coli proteins (Fig. 2). Instead, in
protocol #2, bacterial proteins were separated from lac-
toglobulin in gel filtration step, because most of them have
molecular masses higher than lactoglobulin (Fig. 3).
The observation that protocol #2 allows obtaining a
protein with empty b-barrel indicates that ligand was
trapped in the BlgB b-barrel in the purification process
rather than during expression in E. coli. Binding of fatty
acid might occur e.g. at cell lysis step or later, at low-pH
salting out. Another possibility is that in the acidic envi-
ronment most of the lactoglobulin molecules, especially
those that were not stabilised by a fatty acid, have been
denaturated. Only a small fraction of lactoglobulin mole-
cules with a bound ligand was stable enough to remain
soluble. Such hypothesis would also explain low efficiency
of lactoglobulin purification by protocol #1.
Binding Properties and Stability of sBlgB#2
As ITC showed it, sBlgB#2 can bind model ligand (SDS)
with the stoichiometry 0.8 (Table 2). The value of the
stoichiometry lower than 1.0 is in agreement with our
previous data [22, 34] and was also observed in other
experiments [29]. The binding constant Ka is in good
agreement with reference data obtained from milk protein
[22, 33]. The values of the enthalpy and entropy changes
determined for sBlgB#2 are higher by about 3 kJ/mol but
compensate, giving DG almost the same as observed for
milk protein (Table 2). These data show that recombinant
protein, despite substitutions L1A/I2S introduced at
N-terminus, has binding properties comparable to natural
b-lactoglobulin isolated from milk.
The chemical stability of sBlgB#2 determined by urea-
induced denaturation (Fig. 8) can be described by the two-
state model and is lower than measured by us for com-
mercially available milk protein (Table 3). Survey of
results reported by other authors [21, 47, 48] shows con-
siderable discrepancies, both negative and positive, in the
Cmid values even for data determined spectroscopically at
similar experimental conditions and analysed with the use
of the same model of denaturation (Table 3). It indicates
that not only experimental conditions but also protein ori-
gin might influence obtained values, and such finding
suggests that lower than expected value of chemical
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stability of sBlgB#2 cannot be interpreted as the negative
attribute of recombinant protein.
Similar ambiguous observation concerns lactoglobulin
thermal denaturation parameters (Fig. 8). Determined
Tm value has pointed lower thermal stability of sBlgB#2 in
comparison with milk protein. On the other hand, the
thermal stability of milk lactoglobulin determined previ-
ously spectroscopically at similar experimental conditions
varies in the range 68–80.1 C [49].
Our studies also show that the CD signal dependence on
pH for sBlgB#2 was in agreement with the one recorded
for milk protein (Fig S4). We have limited our investiga-
tions to one method and pH range from 4 to 10, in which
only two conformational transitions of lactoglobulin could
be analysed: so-called N-to-Q transition [50] and Tanford
transition [37]. High similarity of signals from both pro-
teins and their consistency with data measured earlier [38]
indicate in sBlgB#2 and milk protein the same nature of the
conformational changes.
Conclusions
High similarity of L1A/I2S BlgB purified by protocol #2 to
natural protein has been confirmed by CD spectra, calori-
metric studies, crystallization conditions and crystal
structure. Because thermodynamic parameters of ligand
binding are sensitive to pH, ionic strength and temperature,
both sBlgB and milk protein used as a reference were
investigated in the same conditions. All results confirmed
that substitutions of N-terminal residues did not influence
stability and binding properties of the protein significantly.
Therefore, it can be concluded that sBlgB#2 is a good
substitute for natural lactoglobulin which can be used in the
biochemical, biophysical, food and nanomaterials studies.
It is also an excellent starting model for further engineering
which would change its binding affinity towards selected
ligands. New, engineered lactoglobulin with mutations in
region of the binding pocket can potentially have an
application in medicine.
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